Bausch Health's recent performance raises concerns among investors as the stock faced a significant decline.
Bausch Health Companies Inc (BHC.TO) experienced a sharp drop in its stock price yesterday, closing down 5.91% at CA$8.28. This decline follows a brief recovery period, highlighting the volatility that has characterized the stock in recent weeks.
Advertisement
Bausch Health Companies Inc
BHC.TO
BHC.TO
Bausch Health Companies Inc
WealthAwesomeMarket cap
$3.29B
52W high
$11.97
52W low
$6.10
1W change
-1.78%
Beta
0.38
Analyst Price Targets
Based on analyst covering BHC
Wall Street analysts forecast BHC stock price to fall 15.3% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.01
-15.3% Upside
Current Price
C$8.28
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BHC's historical volatility
30-Day Vol
98.1%
Annualized
90-Day Vol
65.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$9.90
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$8.79 | C$6.26 – C$12.33 |
| 60 trading days | C$9.33 | C$5.78 – C$15.05 |
| 90 trading days | C$9.90 | C$5.51 – C$17.79 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should remain cautious as Bausch Health's recent board changes and fluctuating performance may signal deeper issues within the company.
5.91% decline in stock price
Bausch Health's market cap now stands at CA$3.29 billion, reflecting investor uncertainty in the company's future.
Bull case
The recent appointment of CEO Thomas J. Appio to the Bausch + Lomb board could signal a strategic move towards better alignment and focus on core business areas. This could help stabilize the company over time.
Bear case
The stock's significant drop shows ongoing investor concerns about profitability and market confidence, especially with the recent decline in hedge fund participation.
Recent Performance Analysis
Advertisement
Bausch Health's stock decline yesterday is particularly concerning given its recent volatility. After a notable surge of 28.85% just days prior, the sharp drop has left investors questioning the sustainability of its recovery. The stock's performance reflects broader market sentiment and highlights the challenges the company faces in regaining investor trust.
Leadership Changes and Market Reaction
The appointment of Thomas J. Appio to the Bausch + Lomb board aims to enhance governance and oversight. However, investor reaction has been mixed, as shown by the stock's plummet. These changes may not be enough to ease concerns about the company's profitability and strategic direction, especially as hedge fund participation declines.
Looking Ahead
As Bausch Health navigates these turbulent waters, investors will closely monitor upcoming announcements and performance metrics. The company's ability to stabilize its stock and restore confidence will be critical in the coming months, especially in light of its recent struggles.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
